ENVBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Enveric Biosciences, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$1.39+0.01 (+0.72%)
Close on Oct 19, 2026
- Market cap
- $5.54M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Enveric Biosciences's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2026 | Aug 14, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 9, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 8, 2026 | Jun 9, 2026 | SEC EDGAR |
| Current report | 8-K | May 22, 2026 | May 29, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | May 15, 2026 | May 15, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 30, 2026 | Apr 30, 2026 | SEC EDGAR |
| Current report | 8-K | Apr 16, 2026 | Apr 20, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 14, 2026 | Apr 14, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 27, 2026 | Mar 27, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 6, 2026 | Feb 6, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 27, 2026 | Jan 28, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 9, 2026 | Jan 9, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 12, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 11, 2025 | Dec 11, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 14, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 14, 2025 | Nov 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Oct 27, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 22, 2025 | Oct 23, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 17, 2025 | Sep 18, 2025 | SEC EDGAR |
| Current report | 8-K | Sep 2, 2025 | Sep 2, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 26, 2025 | Aug 29, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 14, 2025 | Aug 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 29, 2025 | Jun 3, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 14, 2025 | SEC EDGAR |
| Current report | 8-K | May 14, 2025 | May 14, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Apr 15, 2025 | Apr 15, 2025 | SEC EDGAR |
| Current report | 8-K | Apr 14, 2025 | Apr 14, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 31, 2025 | Mar 31, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 28, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 4, 2025 | Mar 6, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 30, 2025 | Feb 3, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 17, 2025 | Jan 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 3, 2025 | Jan 3, 2025 | SEC EDGAR |